Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis
Completed
Mallinckrodt
Phase 2
2010-08-02
Osteoarthritis (OA) is the most common form of arthritis. It can cause pain, swelling, and
reduced motion in the joints. That can reduce quality of life.
OA can occur in any joint, but usually affects the hands, knees, hips or spine.
The purpose of this study is to find out if doctors might be able to use 2% PENNSAID gel to
treat OA in the knee.
Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel
Completed
Mallinckrodt
Phase 1
2010-09-01
It is anticipated that PENNSAID Gel will minimize systemic exposure versus oral diclofenac
administered twice a day (BID). In addition, PENNSAID Gel should result in greater subject
convenience and compliance with a comparable bioavailability, safety and tolerability profile
to that of the approved PENNSAID solution administered four times a day (QID).
Efficacy of PENNSAID® for Pain Management in the Emergency Department
Withdrawn
Medtronic - MITG
N/A
2011-12-01
The primary objective of this study is to compare the pain relieving effect and speed of
onset of PENNSAID to that of standard oral diclofenac under double blind conditions using a
growth curve approach to pain measurement. The investigators will test the hypothesis that
PENNSAID will provide more rapid pain relief than oral diclofenac during the ED visit. The
secondary goal of the proposed work is to discover and model the onset and course of pain
relief during the emergency department (ED) visit.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
